TherapeuticsMD, Inc. Proceeds from Long-Term Debt Issued
TherapeuticsMD, Inc. (TXMD) reported Proceeds from Long-Term Debt Issued of $75.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2019-02-27
- TherapeuticsMD, Inc. proceeds from issuance of long-term debt for the quarter ending 2018-12-31 was $0.00.
- TherapeuticsMD, Inc. proceeds from issuance of long-term debt for the quarter ending 2018-09-30 was $0.00.
- TherapeuticsMD, Inc. proceeds from issuance of long-term debt for fiscal 2018 was $75.00M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $0.00 derived: sum of 2 quarters · filed 2019-02-27 | $75.00M 10-K · filed 2019-02-27 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $75.00M 10-Q · filed 2018-11-08 | ||
| 2018-06-30 | $75.00M 10-Q · filed 2018-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |